Skip to main content

Table 3 Antimicrobial use among the 9 deceased and 52 non-deceased patients with peritoneal dialysis-related peritonitis caused by a non-tuberculous mycobacterial infection reported since May 2011

From: Peritoneal dialysis-related peritonitis with encapsulated ascites due to Mycobacterium abscessus subsp. massilience and subsp. bolletii: a case series and literature review

 

Deceased (n = 9)

Non-deceased (n = 52)

Aminoglycosides

8 (88.9%)

42 (82.7%)

 Amikacin

6 (66.7%)

30 (57.7%)

 Gentamicin

1 (11.1%)

9 (17.3%)

 Tobramycin

1 (11.1%)

2 (3.8%)

 Isepamicin

0 (0%)

2 (3.8%)

Macrolides

6 (66.7%)

36 (69.2%)

 Clarithromycin

4 (44.4%)

32 (61.5%)

 Azithromycin

2 (22.2%)

3 (5.8%)

 Erythromycin

0 (0%)

1 (1.9%)

New quinolones

1 (11.1%)

25 (48.1%)

 Ciprofloxacin

1 (11.1%)

12 (23.1%)

 Moxifloxacin

0 (0%)

7 (13.5%)

 Levofloxacin

0 (0%)

4 (7.7%)

 Lascufloxacin

0 (0%)

1 (1.9%)

 Sitafloxacin

0 (0%)

1 (1.9%)

Tetracyclines

1 (11.1%)

10 (19.2%)

 Tigecycline

1 (11.1%)

4 (7.7%)

 Minocycline

0 (0%)

3 (5.8%)

 Doxycycline

0 (0%)

3 (5.8%)

Beta-lactams

2 (22.2%)

29 (55.8%)

 Carbapenems

  Imipenem

1 (11.1%)

9 (17.3%)

  Meropenem

0 (0%)

7 (13.5%)

Cephems

 Cephazolin

1 (11.1%)

3 (5.8%)

 Cefoxitin

0 (0%)

4 (7.7%)

 Cefmetazole

0 (0%)

1 (1.9%)

Penicillins

 Ticarcillin/clavulanic acid

0 (0%)

3 (5.8%)

 Piperacillin/tazobactam

0 (0%)

1 (1.9%)

 Flucloxacillin

0 (0%)

1 (1.9%)

Others

 Ethambutol

1 (11.1%)

2 (3.8%)

 Rifampicin

1 (11.1%)

1 (1.9%)

 Linezolid

0 (0%)

7 (13.5%)

 Tedizolid

0 (0%)

1 (1.9%)

 Vancomycin

0 (0%)

9 (17.3%)

 Sulfamethoxazole–trimethoprim

0 (0%)

4 (7.7%)

 Clofazimine

0 (0%)

3 (5.8%)

 Metronidazole

0 (0%)

1 (1.9%)